---
figid: PMC8406585__12974_2021_2226_Fig10_HTML
figtitle: TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid
  hemorrhage
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8406585
filename: 12974_2021_2226_Fig10_HTML.jpg
figlink: /pmc/articles/PMC8406585/figure/Fig10/
number: F10
caption: Schematic diagram for TAK1-mediated neuronal pyroptosis in EBI following
  SAH. The p-TAK1 level is upregulated following SAH ictus. Inhibition of TAK1 by
  OZ treatment reduces ROS production and prevents lysosomal cathepsin B releasing
  into the cytoplasm. ROS and cathepsin B could activate NLRP3 inflammasome. Blockade
  of TAK1 mitigates neuronal pyroptosis via inhibition of NLRP3 inflammasome and NF-κB
  signaling pathway. Treatment with OZ shows remarkable therapeutic effects on EBI
  following SAH
papertitle: TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid
  hemorrhage.
reftext: Pengfei Xu, et al. J Neuroinflammation. 2021;18:188.
year: '2021'
doi: 10.1186/s12974-021-02226-8
journal_title: Journal of Neuroinflammation
journal_nlm_ta: J Neuroinflammation
publisher_name: BioMed Central
keywords: Subarachnoid hemorrhage | TAK1 | Pyroptosis | NLRP3 inflammasome | ROS
automl_pathway: 0.9523902
figid_alias: PMC8406585__F10
figtype: Figure
redirect_from: /figures/PMC8406585__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8406585__12974_2021_2226_Fig10_HTML.html
  '@type': Dataset
  description: Schematic diagram for TAK1-mediated neuronal pyroptosis in EBI following
    SAH. The p-TAK1 level is upregulated following SAH ictus. Inhibition of TAK1 by
    OZ treatment reduces ROS production and prevents lysosomal cathepsin B releasing
    into the cytoplasm. ROS and cathepsin B could activate NLRP3 inflammasome. Blockade
    of TAK1 mitigates neuronal pyroptosis via inhibition of NLRP3 inflammasome and
    NF-κB signaling pathway. Treatment with OZ shows remarkable therapeutic effects
    on EBI following SAH
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACSM3
  - MAP3K7
  - NR2C2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - NFKBIA
  - RPL18
  - IGKV1D-13
  - IGKV1-13
  - IL18
  - KRT5
  - CTSA
  - CTSB
  - CTSC
  - CTSD
  - CTSE
  - CTSF
  - CTSG
  - CTSH
  - CTSK
  - CTSL
  - CTSO
  - CTSS
  - CTSV
  - CTSW
  - CTSZ
  - BTG3
  - NLRP3
  - STS
  - PYCARD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - GSDMD
  - IL1B
  - sah
  - Tak1
  - Dif
  - dl
  - Rel
  - RpL18A
  - l(1)L18
  - RpL5
  - Dd
  - vn
  - ana
  - thr
  - ac
  - ase
  - AstC
---
